Glenmark Pharmaceuticals Shows Mixed Performance Amid Decreased Investor Participation
Glenmark Pharmaceuticals Ltd. has seen significant trading activity today, with nearly 1.73 million shares exchanged. The stock opened at Rs 2,221.0, reached an intraday high, but closed slightly lower. Despite this, it remains close to its 52-week high and continues to trade above key moving averages.
Glenmark Pharmaceuticals Ltd. has emerged as one of the most active equities today, with a total traded volume of 1,729,917 shares and a total traded value of approximately Rs 38.6 crores. The stock opened at Rs 2,221.0 and reached an intraday high of Rs 2,266.0, reflecting a 2.78% increase from the opening price. However, it closed at Rs 2,195.9, marking a slight decline of 0.22% for the day.Despite this dip, Glenmark is currently trading close to its 52-week high of Rs 2,284.8, just 3.57% away. The stock has shown resilience, trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. However, it has underperformed compared to its sector, which saw a 0.33% increase today.
Investor participation appears to be waning, with delivery volume dropping significantly by 63.58% against the 5-day average. Glenmark Pharmaceuticals, a large-cap company with a market capitalization of Rs 62,084.18 crores, continues to navigate a dynamic market landscape. Overall, the stock's performance today reflects a mix of activity and challenges within the broader market context.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
